Robb Milley, PMP

When adding stitching vias to a PCB, strategic placement is crucial. It's essential to position them around the edges of critical components, high-speed signal traces, and ground planes. This ensures effective shielding and enhanced signal integrity. The appropriate size and spacing of stitching vias are chosen based on your application's specific requirements and the PCB's material. #PCBdesign

5

Stitching vias, also known as via stitching, are a crucial design practice for PCBs. By placing a series of vias around the perimeter of a ground plane or signal trace, a continuous conductive path is created, connecting the top and bottom layers of the board. #PCBdesign #viastitching

1

US Domestic IC Assembly - Enhanced Plastic - Old School? Working on a driver IC for space applications at high pin-pin voltage, I find no onshore options besides QFNs with too-fine lead pitch for the voltage. Given low market volumes a custom package development is not a great plan. I'm liking the older quad J-lead / gullwing for their compliant leads (board flex @ shock/vibe or launch, etc.). Only find these at overseas OSAT houses in my searching thus far. Do you like, or fear, hard body non-leaded packages in your application, qualification and launch environment? Could use some insights from the likely users of such a part or those who've gone down this road. Call it 250V pin-pin. Can I count on a general practice of conformal coating which would (in theory) raise the pin-pin potential (volts/distance) suitably (and are the basic PCB creepage specs, all there is to it?) or is New Space so much about cost, that this treatment might be skipped? Based on what you know about board construction, what't your "happy place" for max volts per mm or mil, continuous (VIN) and pulsed (SW)? I'm thinking a 50-mil pitch leaded package (can't see any QFNs at that pitch) might be the answer but would really like to stay onshore. And the whole bit about leaded vs unleaded, I've got mostly old ideas based on hermetic package back-end and strategic systems thermal & mechanical. Anybody know of any legit, space grade, onshore, old school leadframes, good MSL mold compound service providers? I know it's not asking much.

3

That YUG meeting was awesome, a bunch of short talks covering a host of cool yosys FPGA use cases! Mine: 5 minute overview of how to learn and skip the wait for your digital ASIC design, dev and try everything with a drop in replacement FPGA carrier board.

10

We had the pleasure of sitting down with Mayank Varshney, VP of Engineering at Mirafra Technologies. Here's a glimpse into our conversation: 💡His Background: Master's in Electronics & Semiconductor Research from UC Riverside. Industry experience in memory design, digital and mixed-signal design solutions, foundry, and design teams. Joined Mirafra in 2019, bringing a holistic understanding of the chip design industry. 💡His Vision: Focus on career growth for engineers through opportunities. Encourage engineers to set career goals and work together to achieve them. His Observations: Technology industry is shifting towards automation and AI. Data & AI revolution is expanding the technology business. Massive growth in data centers and AI workloads. 💡His Advice for Potential Employees: Come with a belief that you are working on technologies shaping the future. Be passionate about your work and invest in learning. Read the full interview here: https://lnkd.in/d---QRYx #semiconductor #semiconductors #interview 

8

Happy #CostModelMonday! I did a #fan-out panel-level versus wafer-level comparison at #IMAPS DPC this year, and I'm expanding on it for the IMAPS Symposium. I had a single #yield chart in my analysis previously, looking at yield crossover points in relation to how expensive the incoming chip was. I did a new analysis that looks at when the crossover point occurs for two different panel sizes. In this chart, the same package is built with fan-out packaging on a 300mm wafer and from two different panel sizes. The yield for the 300mm wafer example is held steady at 99%, while the yield is changed for the panel-level processes. For the package built with the 515x510mm panel, the crossover point occurs just past 95%. However, the crossover point is closer to 94% for the package from the 600x600mm panel. In other words, a little more yield loss can be sustained by the package from the larger panel before it no longer competes with a higher yielding package from the wafer.

15

It finally arrived the exclusive Virtual Hands-On Labs which will be delivered on Wednesday on May 15, 2024 for the East Coast and, on June 5th, 2024 for the West and East customers. You will have the opportunity to Simplify Secure Chip to Cloud Connectivity using Renesas Cloud Kits. These kits, specifically the CK-RA6M5 and CK-RX65N, are designed to streamline IoT device development and cellular connectivity. Why Your customers should be Interested: Hands-On Experience: Engage in a practical session with the RA6M5 and RX65N Cloud Kits to learn how to effortlessly connect your system to the cloud. Explore IoT Possibilities: Discover the vast potential of monitoring various environmental factors such as temperature, humidity, air quality, and motion. Value Proposition: Ease of Connectivity: Our Renesas family of certified Cloud Kits is designed to make IoT cloud connectivity a breeze, offering multiple connection options for global coverage. Including Renesas WiFi solutions. Registration for the east region https://lnkd.in/gNkFaK4X Registration for the west region https://lnkd.in/gJyxUF9b

15

𝐂𝐮𝐫𝐢𝐨𝐮𝐬 𝐚𝐛𝐨𝐮𝐭 𝐡𝐨𝐰 𝐒𝐞𝐚𝐛𝐫𝐨𝐨𝐤 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐜𝐚𝐧 𝐡𝐞𝐥𝐩 𝐭𝐡𝐞 𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐝𝐞𝐯𝐢𝐜𝐞 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐞𝐫𝐬 𝐬𝐚𝐯𝐞 𝐭𝐢𝐦𝐞 𝐚𝐧𝐝 𝐦𝐨𝐧𝐞𝐲? Register today for an exclusive webinar featuring William Hearne O'Sullivan, CEO of Seabrook Technology, and Keith Bowen, CRO of Seabrook Technology, as they dive deep into the revolutionary impact of advanced digital technologies on the medical device manufacturing industry. Learn how leading manufacturers have unlocked savings by optimizing their production processes. 👉Click here: https://lnkd.in/gBEwj5M5   🗓️ 𝐃𝐚𝐭𝐞: 𝐓𝐡𝐮𝐫𝐬𝐝𝐚𝐲, 𝐉𝐮𝐧𝐞 20𝐭𝐡, 2024  🕛 𝐓𝐢𝐦𝐞: 12 𝐏𝐌 𝐄𝐃𝐓     Don't miss this opportunity to gain invaluable insights and stay ahead of the curve in the rapidly evolving landscape of medical device manufacturing. #MedicalDevices #DigitalTransformation #Webinar #Industry4_0 #SeabrookTechnology #Innovation #HealthcareTechnology 

7

1 Comment

Identify and eliminate recurring errors efficiently with SECA's precise root cause analysis and get suggestive & actionable CAPAs. Simplify your investigative process and ensure consistent improvement with SECA's user-friendly interface, empowering your team to tackle issues head-on and maintain operational excellence. Streamline your error management and enhance your QMS with SECA! #innovation #technology #investigations #linkedin

9

We are here to help you create your Quality Plan for the transition from the QS Regulation to the QMSR. Darren Reeves discusses what that should include in this DP Minute.

3

🚀 Exciting News for Medical Device Manufacturers! 🚀 Comment 81 to the FDA's QMSR addresses the QSIT. 🔎 With the new QMSR, the Quality System Inspection Technique (QSIT) 𝗺𝘂𝘀𝘁 change. Currently in it's 1999 version and based on the 1996's QSR, the FDA is gearing up for a 𝗺𝗮𝗷𝗼𝗿 𝗼𝘃𝗲𝗿𝗵𝗮𝘂𝗹 of the QSIT! 🏥💉 "FDA intends to replace its current inspection approach for medical devices, QSIT, with an inspection approach that will be consistent with the requirements of the QMSR." 💡 Although no real detail on timing or content, FDA is working on the revision to the QSIT and also assessing the impact of the QMSR on the MDSAP. ⏳ "FDA intends to engage in a variety of implementation activities, including: ✅ Training of personnel ✅ Finalizing the inspection approach ✅ Updating information technology systems ✅ Assessing regulations and documents impacted by this rule." ❓Question: Since the current QSIT came about 3 years after the QSR, do you think the QSIT "2.0" will also take 3 years (2026+3=2029 😳)❓ ~~~ If you found this interesting or helpful, consider Reposting 🔄; follow me Vincent F. Cafiso and click the 🔔 so you don't miss future content.

119

79 Comments

📣 We’ve just released the 2024 Regulatory Readiness & Resources Report based on input from nearly 700 respondents! Sponsored content from Celegence: The survey was sent industry-wide, conducted by RAPS and co-sponsored with Celegence, a RAPS partner. The eye-opening results from this benchmark survey informs future trends and investments for the Life Sciences industry. The results are broken out into two different reports to showcase results from both the Pharmaceutical and Medical Device industries Key findings reveal: ✅ Industry is increasing focus on managing resources, with bandwidth/resources the #1 challenge ✅ 77% in Medical Devices, 55% in Pharma have insufficient resources for all of 2024 priorities ✅ AI early adoption use cases include data extraction, report generation and medical writing 👉 Download your copy today: https://bit.ly/4ehay8v A huge thank you to those who participated and contributed to the survey! #regulatory #regulatoryaffairs #regulatorycompliance

7

📣 We’ve just released the 2024 Regulatory Readiness & Resources Report based on input from nearly 700 respondents! Sponsored content from Celegence: The survey was sent industry-wide, conducted by RAPS and co-sponsored with Celegence, a RAPS partner. The eye-opening results from this benchmark survey informs future trends and investments for the Life Sciences industry. The results are broken out into two different reports to showcase results from both the Pharmaceutical and Medical Device industries Key findings reveal: ✅ Industry is increasing focus on managing resources, with bandwidth/resources the #1 challenge ✅ 77% in Medical Devices, 55% in Pharma have insufficient resources for all of 2024 priorities ✅ AI early adoption use cases include data extraction, report generation and medical writing 👉 Download your copy today: https://bit.ly/4ehay8v A huge thank you to those who participated and contributed to the survey! #regulatory #regulatoryaffairs #regulatorycompliance

9

📢Sharing an Insightful Report on our LinkedIn - 2024 Regulatory Readiness & Resources📢 Sponsored content from Celegence: Together with Regulatory Affairs Professionals Society (RAPS), Celegence, a renowned RAPS partner, conducted a comprehensive survey gathering valuable insights from almost 700 respondents across the Life Sciences industry. The findings of this benchmark study will help shape future trends and investments. 📑The survey results are presented in two reports showcasing the Pharmaceutical and Medical Device sectors. 🔑Key Takeaways: 💼 #LifeSciences industry is ramping up efforts in resource management, with bandwidth/resources as the top challenge. 🚨 77% in the #MedicalDevices sector and 55% in Pharma report insufficient resources for their 2024 priorities. 🤖 AI early adoption use cases involve data extraction, report generation, and medical writing. Don't miss out on valuable insights that can impact the future of the Life Sciences industry! https://bit.ly/4ewPQl2

3

PI Expert, our robust online design tool, features schematic and netlist export function made possible by SnapMagic. You can automatically export any power supply design you create in PI Expert to your preferred CAD tool within seconds, saving hours, even days, of development time. Watch this video to learn more -

6

The US Department of Energy is about to condemn the entire population! Through a recent decision to ban the import and sale in the US of lighting that does not meet a minimum "lumens per watt" standard, the DOE is demonstrating its total lack of comprehension of the harm that blue-pumped LEDs can cause. In its blinkered mania to decrease energy consumption, rather than legislating against wasteful uses of energy that serve no beneficial purpose, it is planning to legislate against less energy-efficient forms of lighting than blue-pumped LEDs. In its consideration of the health impact of this ruling, it has only considered emissions reductions: "Health benefits are calculated using benefit-per-ton values for NOx and SO2. DOE is currently only monetizing (for SO2 and NOx) PM2.5 precursor health benefits and (for NOx) ozone precursor health benefits, but will continue to assess the ability to monetize other effects such as health benefits from reductions in direct PM2.5 emissions." The insanity of this beggars belief! 🤡 ...and I thought that #DEFRA were incompetent! This takes it to a whole new level. (Thanks Martin Moore-Ede for the heads up!)

10

8 Comments